Apolipoprotein C-II Amyloid Fibrils Assemble via a Reversible Pathway that Includes Fibril Breaking and Rejoining

Journal of Molecular Biology

Volumn 376, Issue 4, 2008, Pages 1116-1129

  Binger, Katrina J ^a,b   Pham, Chi L L ^a   Wilson, Leanne M ^a   Bailey, Michael F ^a   Lawrence, Lynne J ^b   Schuck, Peter ^c   Howlett, Geoffrey J ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b CSIRO   (Australia)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

amyloid; fibril formation; kinetic analysis; sedimentation velocity; size distribution

Indexed keywords

AMYLOID; APOLIPOPROTEIN C2;

ANTIBODY LABELING; ARTICLE; CONCENTRATION (PARAMETERS); CORRELATION ANALYSIS; DILUTION; KINETICS; PREDICTION; PRIORITY JOURNAL; SEDIMENTATION RATE; TRANSMISSION ELECTRON MICROSCOPY; ULTRASOUND;

EID: 39049110070     PISSN: 00222836     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jmb.2007.12.055     Document Type: Article

References (46)

1. Dobson C.M. Getting out of shape. Nature 418 (2002) 729-730
2. Chiti F., and Dobson C.M. Protein misfolding, functional amyloid, and human disease. Annu. Rev. Biochem. 75 (2006) 333-366
3. Chiti F., Webster P., Taddei N., Clark A., Stefani M., Ramponi G., and Dobson C.M. Designing conditions for in vitro formation of amyloid protofilaments and fibrils. Proc. Natl Acad. Sci. USA 96 (1999) 3590-3594
4. Damaschun G., Damaschun H., Fabian H., Gast K., Krober R., Wieske M., and Zirwer D. Conversion of yeast phosphoglycerate kinase into amyloid-like structure. Proteins 39 (2000) 204-211
5. Fandrich M., Fletcher M.A., and Dobson C.M. Amyloid fibrils from muscle myoglobin. Nature 410 (2001) 165-166
6. Dobson C.M. Protein folding and misfolding. Nature 426 (2003) 884-890
7. Serpell L.C. Alzheimer's amyloid fibrils: structure and assembly. Biochim. Biophys. Acta 1502 (2000) 16-30
8. Bucciantini M., Giannoni E., Chiti F., Baroni F., Formigli L., Zurdo J., et al. Inherent toxicity of aggregates implies a common mechanism for protein misfolding diseases. Nature 416 (2002) 507-511
9. Harper J.D., and Lansbury Jr. P.T. Models of amyloid seeding in Alzheimer's disease and scrapie: mechanistic truths and physiological consequences of the time-dependent solubility of amyloid proteins. Annu. Rev. Biochem. 66 (1997) 385-407
10. Goldstein R.F., and Stryer L. Cooperative polymerization reactions. Analytical approximations, numerical examples, and experimental strategy. Biophys. J. 50 (1986) 583-599
11. Gosal W.S., Morten I.J., Hewitt E.W., Smith D.A., Thomson N.H., and Radford S.E. Competing pathways determine fibril morphology in the self-assembly of beta2-microglobulin into amyloid. J. Mol. Biol. 351 (2005) 850-864
12. Hurshman A.R., White J.T., Powers E.T., and Kelly J.W. Transthyretin aggregation under partially denaturing conditions is a downhill polymerization. Biochemistry 43 (2004) 7365-7381
13. Esler W.P., Stimson E.R., Jennings J.M., Vinters H.V., Ghilardi J.R., Lee J.P., et al. Alzheimer's disease amyloid propagation by a template-dependent dock-lock mechanism. Biochemistry 39 (2000) 6288-6295
14. Carulla N., Caddy G.L., Hall D.R., Zurdo J., Gairi M., Feliz M., et al. Molecular recycling within amyloid fibrils. Nature 436 (2005) 554-558
15. O'Nuallain B., Shivaprasad S., Kheterpal I., and Wetzel R. Thermodynamics of Abeta(1-40) amyloid fibril elongation. Biochemistry 44 (2005) 12709-12718
16. Sengupta P., Garai K., Sahoo B., Shi Y., Callaway D.J., and Maiti S. The amyloid beta peptide (Abeta(1-40)) is thermodynamically soluble at physiological concentrations. Biochemistry 42 (2003) 10506-10513
17. Mucchiano G.I., Jonasson L., Haggqvist B., Einarsson E., and Westermark P. Apolipoprotein A-I-derived amyloid in atherosclerosis. Its association with plasma levels of apolipoprotein A-I and cholesterol. Am. J. Clin. Pathol. 115 (2001) 298-303
18. Haggqvist B., Naslund J., Sletten K., Westermark G.T., Mucchiano G., Tjernberg L.O., et al. Medin: an integral fragment of aortic smooth muscle cell-produced lactadherin forms the most common human amyloid. Proc. Natl Acad. Sci. USA 96 (1999) 8669-8674
19. Hatters D.M., and Howlett G.J. The structural basis for amyloid formation by plasma apolipoproteins: a review. Eur. Biophys. J. 31 (2002) 2-8
20. Hatters D.M., Zhong N., Rutenber E., and Weisgraber K.H. Amino-terminal domain stability mediates apolipoprotein E aggregation into neurotoxic fibrils. J. Mol. Biol. 361 (2006) 932-944
21. Wang L., Lashuel H.A., and Colon W. From hexamer to amyloid: marginal stability of apolipoprotein SAA2.2 leads to in vitro fibril formation at physiological temperature. Amyloid 12 (2005) 139-148
22. Hatters D.M., MacPhee C.E., Lawrence L.J., Sawyer W.H., and Howlett G.J. Human apolipoprotein C-II forms twisted amyloid ribbons and closed loops. Biochemistry 39 (2000) 8276-8283
23. MacRaild C.A., Stewart C.R., Mok Y.F., Gunzburg M.J., Perugini M.A., Lawrence L.J., et al. Non-fibrillar components of amyloid deposits mediate the self-association and tangling of amyloid fibrils. J. Biol. Chem. 279 (2004) 21038-21045
24. Medeiros L.A., Khan T., El Khoury J.B., Pham C.L., Hatters D.M., Howlett G.J., et al. Fibrillar amyloid protein present in atheroma activates CD36 signal transduction. J. Biol. Chem. 279 (2004) 10643-10648
25. Stewart C.R., Haw III A., Lopez R., McDonald T.O., Callaghan J.M., McConville M.J., et al. Serum amyloid P colocalizes with apolipoproteins in human atheroma: functional implications. J. Lipid Res. 48 (2007) 2162-2171
26. Hatters D.M., Minton A.P., and Howlett G.J. Macromolecular crowding accelerates amyloid formation by human apolipoprotein C-II. J. Biol. Chem. 277 (2002) 7824-7830
27. Schuck P. Size-distribution analysis of macromolecules by sedimentation velocity ultracentrifugation and Lamm equation modeling. Biophys. J. 78 (2000) 1606-1619
28. Hatters D.M., MacRaild C.A., Daniels R., Gosal W.S., Thomson N.H., Jones J.A., et al. The circularization of amyloid fibrils formed by apolipoprotein C-II. Biophys. J. 85 (2003) 3979-3990
29. MacRaild C.A., Hatters D.M., Lawrence L.J., and Howlett G.J. Sedimentation velocity analysis of flexible macromolecules: self-association and tangling of amyloid fibrils. Biophys. J. 84 (2003) 2562-2569
30. Hofrichter J., Ross P.D., and Eaton W.A. Kinetics and mechanism of deoxyhemoglobin S gelation: a new approach to understanding sickle cell disease. Proc. Natl Acad. Sci. USA 71 (1974) 4864-4868
31. Smith J.F., Knowles T.P., Dobson C.M., Macphee C.E., and Welland M.E. Characterization of the nanoscale properties of individual amyloid fibrils. Proc. Natl Acad. Sci. USA 103 (2006) 15806-15811
32. Andrianantoandro E., Blanchoin L., Sept D., McCammon J.A., and Pollard T.D. Kinetic mechanism of end-to-end annealing of actin filaments. J. Mol. Biol. 312 (2001) 721-730
33. Sept D., Xu J., Pollard T.D., and McCammon J.A. Annealing accounts for the length of actin filaments formed by spontaneous polymerization. Biophys. J. 77 (1999) 2911-2919
34. Tanaka M., Collins S.R., Toyama B.H., and Weissman J.S. The physical basis of how prion conformations determine strain phenotypes. Nature 442 (2006) 585-589
35. DePace A.H., and Weissman J.S. Origins and kinetic consequences of diversity in Sup35 yeast prion fibers. Nat. Struct. Biol. 9 (2002) 389-396
36. Rubenstein R., Gray P.C., Cleland T.J., Piltch M.S., Hlavacek W.S., Roberts R.M., et al. Dynamics of the nucleated polymerization model of prion replication. Biophys. Chem. 125 (2007) 360-367
37. Bishop M.F., and Ferrone F.A. Kinetics of nucleation-controlled polymerization. A perturbation treatment for use with a secondary pathway. Biophys. J. 46 (1984) 631-644
38. Nowak M.A., Krakauer D.C., Klug A., and May R.M. Prion infection dynamics. Integr. Biol.: Issues News Rev. 1 (1998) 3-15
39. Ohhashi Y., Kihara M., Naiki H., and Goto Y. Ultrasonication-induced amyloid fibril formation of beta2-microglobulin. J. Biol. Chem. 280 (2005) 32843-32848
40. Collins S.R., Douglass A., Vale R.D., and Weissman J.S. Mechanism of prion propagation: amyloid growth occurs by monomer addition. PLoS Biol. 2 (2004) e321
41. Hill E.K., Krebs B., Goodall D.G., Howlett G.J., and Dunstan D.E. Shear flow induces amyloid fibril formation. Biomacromolecules 7 (2006) 10-13
42. Walsh D.M., Klyubin I., Fadeeva J.V., Cullen W.K., Anwyl R., Wolfe M.S., et al. Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-term potentiation in vivo. Nature 416 (2002) 535-539
43. Kirkitadze M.D., Bitan G., and Teplow D.B. Paradigm shifts in Alzheimer's disease and other neurodegenerative disorders: the emerging role of oligomeric assemblies. J. Neurosci. Res. 69 (2002) 567-577
44. Mok Y.F., and Howlett G.J. Sedimentation velocity analysis of amyloid oligomers and fibrils. Methods Enzymol. 413 (2006) 199-217
45. Bohlen P., Stein S., Dairman W., and Udenfriend S. Fluorometric assay of proteins in the nanogram range. Arch. Biochem. Biophys. 155 (1973) 213-220
46. Schuck P., and Rossmanith P. Determination of the sedimentation coefficient distribution by least-squares boundary modeling. Biopolymers 54 (2000) 328-341